Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201110137790N1Phase 2Completed
Phase 2 trial of sufentanil in irreversible pulpitis, sponsored by Islamic Azad University. Primary endpoint: Depth or adequacy of anesthesia. Started Oct 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201110137790N1.